The effects of taking Taltirelin for one month vary from person to person; some patients may experience remission, while others may not experience significant improvement. Taltirelin is a thyrotropin-releasing hormone that has been shown to improve depression, circulatory shock, memory loss, and motor dysfunction. It is used clinically to improve ataxia in patients with spinal cerebellar degeneration. Symptoms may improve in some patients after taking the drug for one month. Common adverse reactions include nausea, vomiting, stomach upset and other symptoms; prohibited in patients who are allergic to the components of the product; patients with renal insufficiency should be used with caution. It should be noted that this drug has not yet been listed in the domestic market, this product needs to be used systematically under the guidance of a doctor, to avoid self-medication or adjusting the dose of the drug lead to adverse reactions or aggravate the condition.